Chris Garabedian`s Xontogeny shepherds two companies through $60M Series A round
13 Dec 2022 //
ENDPTS
Tellus Therapeutics Announces $35 Million Series A Financing
13 Dec 2022 //
BUSINESSWIRE
13 Dec 2022 //
ENDPTS
13 Dec 2022 //
BUSINESSWIRE